Kala Bio (KALA) Payables (2016 - 2026)

Kala Bio has disclosed Payables across 11 years of filings, most recently posting $1.1 million for Q2 2026.

• In Q2 2026, Payables rose 73.56% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (up 73.56% YoY), while the FY2025 annual figure was $986000.0, up 57.01% from the prior year.
• Payables came in at $1.1 million for Q2 2026 at Kala Bio, up from $1.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $10.5 million in Q2 2022 to a low of $628000.0 in Q4 2024.
• Average Payables over 5 years is $2.2 million, with a median of $925000.0 recorded in 2023.
• Year-over-year, Payables surged 270.68% in 2022 and slumped 92.79% in 2023.
• Over 5 years, Payables stood at $2.8 million in 2022, then slumped by 67.55% to $919000.0 in 2023, then plunged by 31.66% to $628000.0 in 2024, then soared by 57.01% to $986000.0 in 2025, then gained by 15.82% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.1 million in Q2 2026, $1.0 million in Q1 2026, and $986000.0 in Q4 2025.